Top Markets
Coin of the day
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Κατάταξη σε μετοχές #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Τιμή μετοχής
$0.035
Τελευταίος συγχρονισμός: 2026-08-13
Κεφαλαιοποίηση
$326.98K
Αλλαγή (1 ημέρα)
-12.50%
Αλλαγή (1 έτος)
-74.55%
Χώρα
US
Εμπόριο Bio-Path Holdings, Inc. (BPTH)

Κατηγορία

Ιστορικό τιμής μετοχής για την Bio-Path Holdings, Inc. (BPTH)
Υψηλότερη τιμή κλεισίματος: $0.04 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $2.50K στις 2006-02-01
Ιστορικό τιμής μετοχής της Bio-Path Holdings, Inc. από 2006 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -9.36%
2025 -91.80%
2024 -91.13%
2023 -66.41%
2022 -65.24%
2021 16.03%
2020 -52.69%
2019 59.95%
2018 -88.85%
2017 -82.76%
2016 -18.86%
2015 -40.35%
2014 -11.72%
2013 803.53%
2012 3.58%
2011 -14.96%
2010 -14.88%
2009 4.80%
2008 -52.90%
2007 18.00%
2006 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE